DrugPatentWatch Database Preview
Drugs in MeSH Category Antibiotics, Antitubercular
» See Plans and Pricing
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Novartis | MYFORTIC | mycophenolic acid | TABLET, DELAYED RELEASE;ORAL | 050791-002 | Feb 27, 2004 | AB | RX | Yes | Yes | Start Trial | Start Trial | Start Trial | |||
Lupin Pharms | RIFAMPIN | rifampin | CAPSULE;ORAL | 090034-001 | Aug 21, 2013 | AB | RX | No | No | Start Trial | Start Trial | Start Trial | |||
Watson Pharms Teva | RIFAMPIN | rifampin | INJECTABLE;INJECTION | 206736-001 | Jan 19, 2016 | AP | RX | No | No | Start Trial | Start Trial | Start Trial | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |